Cargando…
Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
Cancer Institute Chennai is the first Institute of Oncological sciences to be established in the country. In ICON meeting, they presented the data of 516 patients, of which 91% patients achieved complete hematological response. The overall survival was 88% and event free survival was 65% at 5 years.
Autores principales: | Ganesan, Prasanth, Rejiv, R., Manjunath, N., Sanju, C., Sagar, T. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902627/ https://www.ncbi.nlm.nih.gov/pubmed/24516312 http://dx.doi.org/10.4103/0971-5851.123744 |
Ejemplares similares
-
Chronic Myeloid Leukemia in India
por: Ganesan, Prasanth, et al.
Publicado: (2016) -
Report of chronic myeloid leukemia in chronic phase from Dr. Senthil Rajappa, 2002-2009
por: Rajappa, Senthil, et al.
Publicado: (2013) -
Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term Outcome
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2016) -
Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009
por: Agarwal, M. B., et al.
Publicado: (2013) -
Report of chronic myeloid leukemia in chronic phase from Eastern India, Institute of Hematology and Transfusion Medicine, Kolkata, 2001-2009
por: Ray, Siddhartha Sankar, et al.
Publicado: (2013)